ARHGEF3 and multiminicore myopathy: What we captured in this study is that ARHGEF3 likely contributes to angiogenesis through the activation of RHOA/ROCK signaling, and its downregulation by miR-512-3p may be involved in the development of aberrant angiogenesis in MMD.